Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.62 |
| ▸ | THRB | P10828 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 4/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | APEX1 | P27695 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | ACHE | P22303 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 3/20 | 0.31 |
| ▸ | CA2 | P00918 | 3/20 | 0.31 |
| ▸ | MGAM | O43451 | 2/20 | 0.30 |
| ▸ | GAA | P10253 | 2/20 | 0.30 |
| ▸ | SI | P14410 | 2/20 | 0.30 |
| ▸ | MGAM2 | Q2M2H8 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10714186 | 1.00 | ALDH1A1 (0.62) | ALDH1A1THRBTSHRPOLBAPEX1 | |
| Methacrylic Acid SCHEMBL1720191 | 0.94 | ALDH1A1 (0.56) | ALDH1A1THRBTSHRPOLBAPEX1 | |
| SCHEMBL10823130 | 0.93 | THRB (0.55) | ALDH1A1THRBTSHRPOLBAPEX1 | |
| Methoxymethane SCHEMBL302708 | 0.91 | THRB (0.55) | ALDH1A1THRBTSHRPOLBAPEX1 | |
| SCHEMBL29229747 | 0.91 | THRB (0.59) | ALDH1A1THRBTSHRPOLBAPEX1 | |
| SCHEMBL6864388 | 0.91 | THRB (0.59) | ALDH1A1THRBTSHRPOLBAPEX1 | |
| SCHEMBL14886 | 0.91 | — | — | |
| Methacrylic Acid SCHEMBL9453511 | 0.89 | ALDH1A1 (0.50) | ALDH1A1THRBTSHRPOLBAPEX1 | |
| SCHEMBL1291892 | 0.89 | ALDH1A1 (0.71) | ALDH1A1THRBTSHRPOLBAPEX1 | |
| Ethylene SCHEMBL1248384 | 0.89 | THRB (0.57) | ALDH1A1THRBTSHRPOLBAPEX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 369 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119979690-A | SNP-STR composite genetic marker detection kit and application thereof | 广西医科大学 | 2025-05-13 | — | — | CN | claimed |
| CN-116983987-A | Iron-based MOF, induced titanium dioxide composite catalyst, preparation method and application | 西安近代化学研究所 | 2023-11-03 | — | — | CN | claimed |
| CN-109897204-B | Large-area water-writing color development colorless transparent photonic crystal film and preparation method thereof | 大连理工大学 | 2022-03-22 | — | — | CN | claimed |
| CN-108066825-B | Preparation method of medical flexible gradual change vascular catheter | 杭州鑫泽源精密制品有限公司 | 2020-02-07 | — | — | CN | claimed |
| EP-3297574-B1 | CAPSULE TENSIONING RING | FEUSI MARCO (CH) | 2019-08-07 | — | — | EP | claimed |
| CN-103901722-B | Alkaline imaging photosensitive resin composition and preparation method thereof | 无锡德贝尔光电材料有限公司 | 2017-02-22 | — | — | CN | claimed |
| CN-101868241-A | Therapeutic gene switch constructs and bioreactors for expression of biotherapeutic molecules and uses thereof | INTREXON CORP | 2010-10-20 | — | — | CN | claimed |
| US-20100184121-A1 | Removal of by-products from crosslinkable preparations | HENKEL AG & CO. KGAA (DE) | 2010-07-22 | — | — | US | claimed |
| EP-2205249-A2 | THERAPEUTIC GENE-SWITCH CONSTRUCTS AND BIOREACTORS FOR THE EXPRESSION OF BIOTHERAPEUTIC MOLECULES, AND USES THEREOF | Intrexon Corporation (US) | 2010-07-14 | — | — | EP | claimed |
| US-20090136465-A1 | Therapeutic Gene-Switch Constructs and Bioreactors for the Expression of Biotherapeutic Molecules, and Uses Thereof | INTREXON CORPORATION (US) | 2009-05-28 | — | — | US | claimed |
| EP-0876151-A1 | MICROENCAPSULATED GENETICALLY ENGINEERED MICROORGANISMS FOR CLINICAL APPLICATION | McGILL UNIVERSITY (CA) | 1998-11-11 | — | — | EP | claimed |
| WO-1997026903-A1 | MICROENCAPSULATED GENETICALLY ENGINEERED MICROORGANISMS FOR CLINICAL APPLICATION | MCGILL UNIVERSITY (CA) | 1997-07-31 | — | — | WO | claimed |
| WO-1997016176-A1 | ANGIOGENIC MATERIAL AND USES THEREOF | SEFTON MICHAEL VIVIAN (CA) | 1997-05-09 | — | — | WO | claimed |
| US-5614223-A | HYDROXYETHYL METHACRYLATE-METHYL METHACRYLATE COPOLYMER COATINGS | DIGESTIVE CARE INC. (US) | 1997-03-25 | — | — | US | claimed |
| US-RE35049-E | Image receptive layer, electroconductive layer, support; controlled abrasivity | ARKWRIGHT, INCORPORATED (US) | 1995-10-03 | — | — | US | claimed |
| US-5433952-A | Intraoral medicament-releasing device | DIGESTIVE CARE INC. (US) | 1995-07-18 | — | — | US | claimed |
| EP-0454233-B1 | A film composite for electrostatic recording | ARKWRIGHT INC (US) | 1995-07-05 | — | — | EP | claimed |
| EP-0569797-A2 | Intraoral device for slow medicament release | DIGESTIVE CARE INC. (US) | 1993-11-18 | — | — | EP | claimed |
| US-5126763-A | FILM COMPOSITE FOR ELECTROSTATIC RECORDING | ARKWRIGHT INCORPORATED (US) | 1992-06-30 | — | — | US | claimed |
| EP-0454233-A1 | A film composite for electrostatic recording | ARKWRIGHT INC. (US) | 1991-10-30 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090136465-A1 | Therapeutic Gene-Switch Constructs and Bioreactors for the Expression of Biotherapeutic Molecules, and Uses Thereof | GMFG, IL2RA, IL2 | ALDH1A1 1571/4885THRB 659/4885TSHR 1965/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.